Senior General Manager - Quality Assurance appointed as Senior Management Personnel
Mr. Pradeep Kumar Yadav has been appointed Senior General Manager - Quality Assurance and designated as Senior Management Personnel, effective 24th September, 2026.
By ScoutQuest · · 1 min read
- Appointee Name
- Mr. Pradeep Kumar Yadav
- Position
- Senior General Manager - Quality Assurance
- Effective Date
- 24th September, 2026
- Industry Experience
- Over 20 years of pharma industry experience
- Regulatory Exposure
- USFDA, MHRA, TGA, WHO Geneva and others
What happened
Lincoln Pharmaceuticals has told the stock exchanges about a change in its senior management team.
- Mr. Pradeep Kumar Yadav has been appointed as Senior General Manager - Quality Assurance.
- The appointment is effective from September 24, 2026.
- He has been designated as Senior Management Personnel of the company.
- The reason for the change is stated as an appointment (not a replacement or resignation disclosure).
Background of the appointee
- Over 20 years of experience in the pharmaceutical industry.
- Expertise in Quality Management Systems (QMS), audit compliance, validation and qualifications.
- Knowledge of IPQA and vendor management.
- Direct involvement in customer audits and international regulatory inspections by USFDA, MHRA, TGA, ENVISA, WHO Geneva and SAPHRA.
Where he will work
He will be based at the company's manufacturing facility at Trimul Estate, Khatraj, in Gandhinagar district, Gujarat.
Terms in the appointment letter
- Probation period of 06 months from the date of joining, extendable at management's discretion.
- Notice period of 30 days during probation and 90 days after confirmation.
- A bond of 2 years minimum, with a cheque equal to 2 months CTC submitted; refundable after completion of 2 years.
- Retirement age of 58 years.
- Performance review on April 1st each year.
How investors may read this
For a pharmaceutical manufacturer, quality assurance leadership is closely linked to regulatory inspections and audit outcomes at plants. The appointee's stated exposure to USFDA, MHRA, TGA and WHO inspections is relevant to that function. This is a routine disclosure of a senior management change and does not by itself carry any financial figures relating to the company's business or earnings.
Also from Lincoln Pharmaceuticals
Board meeting on 29 October 2026 to consider unaudited results for September quarter
22 Oct 2026
Senior General Manager - Quality Assurance resigns with effect from October 17, 2026
17 Oct 2026
Head of Quality Assurance resigns with effect from September 24, 2026
24 Sep 2026
More numbers
- Experience in pharmaceutical industryover 20 years
- Probation period06 months
- Notice period during probation30 days
- Notice period after confirmation90 days
- Bond period2 years
- Cheque equal to months of CTC under bond2 months CTC
- Retirement age58 years
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.